Results: A novel ER stress-responsive element, ERSE-26, identified in 38 human genes, including PRNP and ERLEC1, is regulated by spliced XBP1 during ER stress. Conclusion: ER stress increases the levels of human prion protein and other proteins not previously known to be involved in the ER stress response. Significance: ERSE-26 implicates novel genes and cellular functions regulated by the ER stress response.
eliminates infection by transmissible prion diseases and low levels of PRNP gene expression associated with promoter nucleotide polymorphisms decreases the risk of infection by bovine spongiform encephalopathy (1) (2) (3) . In contrast, transgenic over-expression of PRNP accelerates transmissible prion disease progression (1, 4, 5) . In addition, polymorphisms in the regulatory region of PRNP may present a risk for Creutzfeldt Jakob Disease (6, 7) . Furthermore, accruing evidence implicates the normal cellular PrP in a number of essential cellular functions including neuroprotection against oxidative stress (8, 9) , copper toxicity (10) , Bax-mediated cell death (11) , and ischemia (12) (13) (14) (15) . There is also evidence that PrP participates in normal synaptic function (16) , and myelination (17, 18) . Fully understanding the regulation of PRNP gene expression is essential to developing therapies against transmissible prion diseases and will also help elucidate the function of the normal cellular PrP.
PrP is developmentally and ubiquitously expressed in most organs and tissues with a higher expression in brain, lung, heart, and muscle (19) (20) (21) (22) (23) (24) (25) . The PRNP promoter contains G-C rich repeats, which are common to housekeeping genes. It does not contain the core promoter TATA box sequence, but does contain Sp1, Ap-1, Ap-2, and CCAAT box transcriptional binding sites (26, 27) . Regulatory elements include MyoD, heat shock elements (28), and metal regulatory element MTF-1 (29). Upregulation of PRNP gene expression occurs via NGF (30), or hypoxic conditions in brain (15, 31) , in HIV infection of astrocytes (32), during hematopoietic differentiation (24), by cellular exposure to copper (29), and has been associated with a change in chromatin conformation (33).
We recently identified four endoplasmic reticulum stress response elements (ERSE) in the PRNP promoter and showed that ER stress transcriptionally upregulates PRNP gene expression (34). The unfolded protein response (UPR) is a well-conserved process that cells use to restore ER homeostasis or enter apoptosis. In higher eukaryotes, three sensors of ER status exist (reviewed by (35)). The Inositol Requiring Enzyme 1 (IRE1α) is a transmembrane ribonuclease that splices and activates X-Box Binding protein (XBP1) mRNA when the foldase BiP (Grp78, encoded by HSPA5) dissociates from IRE1α and preferentially attaches to mis-folded client proteins (35, 36) . Concurrently, the transmembrane protein Activating Transcription Factor 6 (ATF6α), which is normally bound by BiP, is released and translocates to the Golgi complex, where it is cleaved by the transmembrane Site 1 and Site 2 proteases to form a highly active transcription factor (37, 38) . The third branch of ER stress signal transduction is mediated by the transmembrane PKR-like ER Localized Kinase (PERK), which upon BiP dissociation phosphorylates eukaryotic translation initiation factor 2 (eIF2α). Phosphorylation of eIF2α arrests translation of most messages, except for several with upstream activating open reading frames, such as the Activating Transcription Factor 4 (ATF4) mRNA (35, 39) . Following ER signal transduction, spliced XBP1 (sXBP1), cleaved ATF6 (ΔATF6α) and ATF4 translocate to the nucleus where they are able to activate the expression of ER stress responsive genes. ΔATF6α, sXBP1 or ATF4 interact with several promoter DNA motifs called ERSE, resulting in transactivation of UPR target genes (35) .
One of the PRNP ERSE, CCAAT separated from CCACG by 26 nucleotides (CCAAT-N26-CCACG or ERSE-26), was of particular interest, as it resembled almost exactly the classical ERSE, CCAAT-N9-CCACG (ERSE-9) characterized by Yoshida and colleagues in ER stress upregulation of glucose-regulated proteins (37) . The ERSE-9 is transactivated by ΔATF6α (36,37) . While the XBP1 can bind to the ERSE-9 and transactivate a luciferase reporter under the regulation of 5 tandem repeats of the ERSE-9 (40), overexpression of XBP1 did not transactivate the glucose-regulated proteins (36). Separation of the CCACG from CCAAT with 8, or 10 to 13 nucleotides instead of nine nucleotides abolished the ability of ∆ATF6 to bind to the ERSE-9 motif (36,37). Therefore, it would be expected that the PRNP CCAAT-N26-CCACG might not be transactivated by ∆ATF6α. Nevertheless, the homology of the PRNP ERSE-26 with the classical ERSE-9 and the ability of ER stress to induce PRNP gene expression (34), prompted us to further investigate this motif. We find that the ERSE-26 is transactivated by sXBP1 at the CCACG motif but is not transactivated by ∆ATF6α. A bioinformatic analysis of the human genome revealed 37 other genes containing the ERSE-26 within their promoter region. Several were confirmed to be upregulated by ER stress in primary human neuron cultures or in the breast carcinoma MCF-7 cell line. These results identify a novel ER stress-regulated ERSE motif that is common to 38 human genes.
Experimental Procedures

Genome-wide search for genes bearing an ERSE-26
In order to find genes in the human genome with an ERSE-26 in their promoter, a program was written in Python. The sequence of the complete human genome, version GRC37.1 from the Genome Reference Commission (41), yeast genome (S. Saccharomyces S288c-NCBI) were scanned using regular expressions representing the plus and minus strand versions of the ERSE-26. The promoters of all human genes were searched. The region from -2,000 bp upstream of the transcription start site (TSS) to +500 bp downstream of the TSS was considered to be the promoter region of the gene. The Regular Expression pattern used was "ccaat. 26ccacg", matching precisely (no deviations were permitted). Both ERSE-26 elements in forward and reverse orientations were searched. Additionally, promoters in the positive and negative strands of the genome were examined. Source code is provided in a Git repository: (https://www. github.com/networkdynamics/erse-like-promotersanalysis).
Cell culture conditions
Human primary neuron cultures, obtained from human fetal brains subject to McGill University ethical approval, were cultured as previous described (42) . Briefly, brains were minced, trypsinized, plated on poly-lysine coated flasks and grown in the presence of 5-fluorodeoxyuridine, 1X Penicillin Streptomycin and minimum essential media (MEM) media supplemented with 10% bovine calf serum in a 5% CO 2 environment at 37° C. MCF-7 cells (ATCC) were grown in Roswell Park Memorial Institute (RPMI) media supplemented with 10% Fetal Bovine Serum (FBS) in a 5% CO 2 environment at 37° C. HEK293 cells were grown in Dulbecco's Minimum Essential Media (DMEM) supplemented with 1.7 g/L NaHCO 3 and 10% fetal bovine serum (FBS) in a 5% CO 2 incubator at 37° C.
Pharmacological induction of ER Stress and other cell treatments
Neurons and MCF-7 cells were subjected to ER stress, under conditions experimentally optimized to minimize cell death and maximize ER stress induction. In neurons, ER stress was induced by 5 µg/mL Brefeldin A (BFA), 0.5 µg/mL Tunicamycin (TM) and 3.25 µg/mL Thapsigargin (Thps) from Biomol. Drugs were dissolved in dimethyl sulfoxide (DMSO), and cells were treated for 6h using the equivalent concentration of DMSO as control, followed by immediate total RNA extraction. MCF-7 cells were treated for 18h with all drugs at a concentration of 5 µg/mL.
Total RNA extraction and Reverse-Transcriptase Polymerase Chain Reaction
Total RNA was extracted from neurons using Trizol (Invitrogen) as described by the manufacturer's protocol. For MCF-7 cells, the Chomczynski Guanidine Thiocyanate method was used (43) . RNA was quantitated on an H4 plate reader (Biotek, Winooski, VT) for neurons, or a Nanodrop ND-1000 spectrophotometer (Thermo Scientific). cDNA was prepared using avian myeloblastosis reverse transcriptase (AMV-RT), following the manufacturer's protocol (Roche). Briefly, 1µg total RNA was used for cDNA synthesis by AMV-RT with poly-dT primers, and cDNA used as a template for subsequent PCRs.
Primer Design and PCR of ERSE-26 genes
For PCRs, primers were designed using the NCBI PrimerBlast software available online at http://www.ncbi.nlm.nih.gov/tools/primer-blast/ (44) . Primers were designed to have an annealing temperature of 60° C. All oligonucleotides were ordered from a commercial supplier (Invitrogen), and optimized with a gradient of annealing temperatures. Table I contains all primer sequences. During all subsequent PCRs, the optimal annealing temperature of a gene's primer pair was always used. cDNA was diluted to 1:200 and PCR was performed with Taq DNA polymerase (NEB), following the manufacturer's protocol. Three biologically independent neuron preparations were used, and two technical replicates per gene per preparation were tested. For MCF-7 cells, three independent experiments were conducted in triplicate for all ER stress drug treatments and sXBP1 transfections.
Western Blotting of PrP, BiP and β-actin in ER stress treated neurons Cells were lysed for 20 min on ice in 150 mM NaCl, 2 mM EDTA, 0.5% Triton X-100 (v/v), 0.5% sodium deoxycholate (NaDOC) (w/v), 50 mM Tris-HCl, pH 7.5 lysis buffer containing fresh protease and phosphatase inhibitors (38µg/mL AEBSF, 0.5µg/mL leupeptin, 0.1µg/mL pepstatin, 0.1µg/mL N-α-p-tosyl-L-lysine chloromethyl ketone hydrochloride, 4 mM sodium orthovanadate, 20 mM sodium fluoride). After centrifugation of the lysate at 11 500 x g for 10 min at 4˚C, the supernatant was collected as the detergent soluble fraction. The protein concentration was determined with the BCA Protein Assay Reagents (Fisher, Nepean, ON). One hundred µg of protein was precipitated with 4 volumes of ice-cold methanol overnight at -20˚C, centrifuged at 11 500 x g for 15 min at 4˚C and the dried pellet solubilized in Laemmli sample buffer (2% SDS (w/v), 5% β-mercaptoethanol, (v/v), 10% glycerol (v/v), 0.01% bromophenol blue (w/v), 62.5 mM Tris-HCl, pH 6.8). The proteins were boiled for 3 min, separated in a 10% or 15% SDS-PAGE gel and transferred to PVDF membranes. PrP was detected with the polyclonal R155 antiserum ( 
Cloning of ERSE-26 fragment into pMetLuc2
vector and site-directed mutagenesis. The pMetLuc2-Reporter construct (pML2, obtained from Clontech) is a plasmid that encodes a luciferase gene from the copepod Metrida Longa. This gene contains a powerful endogenous signal peptide, causing the protein to be secreted into the growth media. This allows for a no-lysis protocol for assaying luciferase activity in transfected cells by simply reading the luciferase activity (when a substrate is added) of the media. To clone the PRNP promoter fragment into pML2, primers were designed to amplify the region from -391bp to -274bp, around the ERSE-26, which was obtained from the pGL3 PRNP promoter construct kindly given to us by the laboratory of Dr. Collinge (26) . The following primers were used (restriction sites in bold): Forward 5'-GAG CTC TCT CCA TTA TGT AAC GGG GA-3', Reverse 3'-GCG AAT TCT CAG TTG ATA CCG CCT GCG G-5'. Primers contained the restriction endonuclease sites for EcoRI and SacI. The PCR product and pMetLuc2-reporter vector was digested using EcoRI and SacI, followed by ligation with T4 DNA Ligase (Fermentas). DH5α E. coli were transformed using standard protocols and DNA was prepared for transfection using the alkaline lysis method (45) . The resulting pML2-EL26 construct was sequenced. Following cloning of the PRNP promoter fragment into the pMetLuc2 vector, the ERSE-26 was mutated by PCR with mutagenic oligos. Primers were designed to target the second part of the ERSE-26, the putative XBP1/ATF6 binding site: CCACG was changed to ATCTA. Two additional basepairs after the XBP1/ATF6 site were also changed from TC to GA, yielding a final mutation of ATCTAGA. The following primers were used for mutagenesis, with the mutation in bold, and the former location of the CCACG site underlined: 5'-GAT TTT TAC AGT CAA TGA GAT CTA GAA GGG AGC GAT GGC ACC C-3' and 5'-GGG TGC CAT CGC TCC CTT CTA GAT CTC ATT GAC TGT AAA AAT C-3'. In addition, two other mutants were generated by inserting four or eight base pairs at the center of the ERSE-26 element. For the elongated ERSE-30 and ERSE-34, the following primers were used, with the inserted base pairs underlined: ERSE-30-For 5'-GGG CCG AAT TTC CAA TTA AAG ATG ATT TTA AAA TAC AGT CAA TGA GCC ACG TCA GGG AGC G-3' and ERSE-30-Rev 5'-CGC TCC CTG ACG TGG CTC ATT GAC TGT ATT TTA AAA TCA TCT TTA ATT GGA AAT TCG GCC C-3' and ERSE-34-For 5'-GGA GCT TTG GGC CGA ATT TCC AAT TAA AGA TGA TTT TAA AAA AAA TAC AGT CAA TGA GCC ACG TCA GGG AGC GAT GGC AC-3' and ERSE-34-Rev 5'-GTG CCA TCG CTC CCT GAC GTG GCT CAT TGA CTG TAT TTT TTT TAA AAT CAT CTT TAA TTG GAA ATT CGG CCC AAA GCT CC-3'. DNA was synthesized using Pfu Turbo (Agilent Technologies) and subject to DpnI digestion to remove non-mutated plasmid DNA. DNA was then transformed into DH5α E. coli using standard techniques and prepared using the alkaline lysis method. Transfection in HEK293 cells was done as before.
Transfection of HEK293 cells and Luciferase assay
HEK293 cells were plated in 6 well plates at approximately 500,000 cells/well. Twenty-four hours after plating, using the polyethyleneimine (PEI) method (46), cells were transfected with pMetLuc2-Reporter-ERSE-26, pMetLuc2-Reporter-ERSE-30 or pMetLuc2-Reporter-ERSE-34 and plasmids pCGN-EGFP, pCGN-ATF6 encoding ΔATF6α (amino acids 1-373) or pCGNsXBP1 kindly provided by Dr. Kaufman (40) . Following 6h of transfection, media was changed, and cells were allowed to grow for 20h. After 20h, media was collected. Luciferase assays were conducted on 50 µl of HEK293 growth media. Substrate (Ready-to-Glow Secreted Luciferase substrate, Clontech) for the luciferase protein was prepared according to the manufacturer's protocols. Assays were conducted in a 96-well white, opaque plate (Costar) and total luminescence was determined using an H4 plate reader (Biotek, Winooski, VT). At least two reads were conducted per well, in three biologically independent experiments. As a control, total RNA was extracted as before to verify sXBP1 and ATF6α transcripts in transfected cells.
Western Blotting of XBP1 and ATF6α in HEK293 cells
HEK293 cells were extracted with NP-40 lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1% NP-40, 5 mM EDTA pH 8.0). Extracts were separated by 10% SDS-PAGE, transferred using a BioRad Transblot Turbo apparatus to PVDF membrane, blocked 1h in 5% milk, then incubated with 1:100 anti-XBP1 (sc7160, Santa Cruz) or 1:100 anti-ATF6 (IMG-273, Imgenex) to confirm expression of transgenes. Membranes were detected using anti-mouse/rabbit IgG horseradish peroxidase at 1:5000 in 5% milk (Jackson) and visualized with ECL Prime (GE Healthcare) on Kodak BioMax MR Film.
Transfection of MCF-7 cells
MCF-7 cells from ATCC (Manasas, VA) were cultured as described above and transfected with Nucleofector Kit V following the manufacturer's protocol (Amaxa TM ). Cells were transfected with either pCGN-EGFP-sXBP1 (pCGN-sXBP1) or vehicle (pCGN-EGFP) kindly given by the laboratory of Dr. Kaufman (40, 47) . The siRNAs against XBP1 were obtained from Santa Cruz (sc38627) as well as scrambled siRNA controls (sc37007). Total RNA was extracted using Chomczynski's method, and cDNA was synthesized using AMV-RT as before. Primers were verified for specificity and performance for qPCR. All output was converted to fold-induction values compared to control treatments normalized with loading controls (HPRT1), using Pfaffl's method (49) . In the siRNA experiments, we observed too much variability in the HPRT1 levels with siRNA and drug treatments; therefore the data was normalized to GAPDH.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were performed as described previously with some modifications (34). MCF-7 cells transfected with either pCGN-XBP1 or pCGN-ATF6 were incubated with 1% formaldehyde for 10 min at 37 °C. The cross-linking was stopped with glycine at a final concentration of 0.125 M. After 5 min at 37 °C, cells were lysed in swelling buffer (10mM Tris-HCl pH 8, 0.25M sucrose, 0,5% NP-40, 2mM DTT) containing fresh protease inhibitors (38 µg/ml AEBSF, 0.5 µg/ml leupeptin, 0.1µg/ml pepstatin and 0.1 µg/ml TLCK), and incubated for 20 minutes on ice in sonication buffer (50 mM Hepes pH 7.4, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 1% SDS, protease inhibitors). Nuclear lysates were sonicated to shear the genomic DNA into fragments of 200-1000 bp. The chromatin was precleared with Protein G-Sepharose (Sigma) precoated with 1 µg/mL sonicated salmon sperm nuclei (S3126, Sigma) and 1 mg/mL BSA. Chromatin was then incubated overnight with precoated Protein G-Sepharose and anti-ATF6 (IMG-273, Imgenex), anti-XBP1 (sc7160, Santa Cruz), control IgG antibodies (3 g) or no antibody. After washing, the immunoprecipitates were eluted two times with 200 µl of elution buffer (50 mM NaHCO 3 , 1% SDS, 1 mM EDTA and 50 mM Tris-HCl pH 8.0). Cross-linking was then reversed overnight at 65 °C. The immunoprecipitated and whole cell extract DNA were purified and used for PCR analyses using primers designed to amplify only the ERSE-26 of PRNP: PRNP sense 5 -CTGAGCCTTTCATTTTCTCG-3 and antisense 5 -GAGATTCGCTTGAACACTTG-3 ; HSPA5 sense 5 -GTGAACGTTAGAAACGAA TAGCAGCCA -3 and antisense 5 -GTCGAC CTCACCGTCGCCTA -3 , and ACTB sense 5 -CTGGAACGGTGAAGGTGACA -3 and antisense 5 -AAGGGACTTCCTGTAACAATG CA -3 . The PCR products were visualized after electrophoresis on a 3% agarose gel containing ethidium bromide.
Data mining of existing databases.
Microarray databases in GeoDataset (NCBI) were explored for evidence of increased HSPA5 mRNA levels as evidence for ER stress. The GeoDataSet named "In vitro generation of long-lived human plasma cells" (50) compared Illumina microarray profiles (Illumina Human HT-12 V4.0 expression beadchip) of human adult peripheral B cells differentiated into plasma cells. A significant fold change was taken when genes identified to contain ERSE-26 had an adjusted p value of p<0.05.
Statistical analysis
For the luciferase assays, a one-way analysis of variance followed by Tukey's Honest Simple Difference post-hoc test was used to determine whether or not luminescence values were statistically significant. For qPCR data, a treatment by gene ANOVA followed by Tukey's HSD post hoc analyses, pairwise one way t-test, or as indicated in the figure legends on individual means (using SPSS version 17) was conducted on fold increases in cDNA amplicons.
Results
sXBP1, not ∆ATF6α, transactivates ERSE-26
To determine if the ERSE-26 responds to ER stress-regulated transcription factors ATF6α and sXBP1, human embryonic kidney HEK293 cells were co-transfected with the pML2-ERSE-26 luciferase reporter construct and pCGN-sXBP1 or pCGN-ATF6(1-373) encoding ∆ATF6α. Cotransfection of pML2-ERSE-26 and sXBP1 resulted in high luciferase activity (Fig. 1A) , whereas non-transfected cells, mock transfected cells, or cells transfected with only pML2-ERSE-26, pCGN-sXBP1 or pCGN-ATF6(1-373), showed little luciferase activity. Mutagenesis of the putative ATF6α/sXBP1 binding site CCACG to ATCTA in the ERSE-26 (pML2-ERSE26m) abolished transactivation by sXBP1 (Fig. 1B) . RT-PCR (Fig. 1C) and western blots (Fig. 1D) confirmed the expression of sXBP1 only in cells transfected with the pCGN-sXBP1 construct. In contrast to sXBP1, ΔATF6α did not activate ERSE-26-mediated transcription (Fig. 1A&B) . Again, RT-PCR (Fig. 1C) and western blots (Fig.  1D) (Fig. 1E) . Lastly, ChIP analyses confirmed the interaction of sXBP1 with ERSE-26 (Fig. 1F) . In contrast, ATF6α did not co-immunoprecipitate the ERSE-26 (Fig. 1G) . Together, these results indicate that sXBP1, not ∆ATF6α, is the transactivating factor for the ERSE-26 motif.
ERSE-26 motif identified in the promoters of 37 additional human genes
To assess if the ERSE-26 is present in the promoter of genes other than PRNP, a Python program was written to search the Genome Reference Consortium human genome (Build GRC37.1). In total, 38 genes contained an ERSE-26 within -2000bp and +500bp from the transcription start site of the gene ( Table II) . None of these genes contained canonical ERSEs except C6orf20, which contained an ERSE-II motif, and GADD45B and LRRC55, which contain XBP1 binding sites in their promoters. Twenty-six ERSE-26 matches were found in the reverse (3' to 5') direction, and 12 were found in the forward direction. As a control for the search program, the search was repeated with the canonical ERSE-9 as a target pattern. Forty-four genes, including the previously known ERSE-containing genes HSPA5 (BiP, Grp78), XBP1 and PDIA6 contained an ERSE-9 within 2000bp and +500bp from the transcription start site of the gene (Table III) . These results show that the ERSE-26 motif is not unique to the PRNP promoter and suggest that ER stress may regulate a wide variety of genes previously unsuspected to be involved in the ER stress response.
To assess if ERSE-26 is evolutionarily conserved, we searched the yeast genome. The search identified 8 yeast genes containing ERSE-26 (Table IV) , but none of these were the same as the mammalian ERSE-26 genes. However, three of the 8 genes may be relevant to ER function. Fun12p functions as a translation initiation factor (51), Chs6p is involved in Golgi to plasma membrane protein trafficking (Saccharomyces Genome Database), and Hap1p is a zinc finger transcriptional factor responding to oxygen and heme levels (52) . These data indicate that the ERSE-26 exists in lower organisms but not necessarily in orthologous genes to the mammalian ERSE-26 genes.
ERSE-26 genes are up-regulated in primary human neuron cultures treated with BFA, TM or Thps
To confirm that the ERSE-26 containing promoters are transactivated during ER stress, primary human neurons were treated with ER stressors, Brefeldin A (BFA), Tunicamycin (TM), or Thapsigargin (Thps) (Fig. 2) . RT-PCR identified transcripts from 20 of the 38 ERSE-26 genes in primary human neuron cultures (Fig. 2A) . ER stress induction under these conditions was confirmed by the presence of sXBP1 amplicon ( Fig. 2A, B) , or increased HSPA5 (BiP) mRNA (Fig. 2B) or protein (Fig. 2C) levels. The levels of ER stress-induced sXBP1 varied with the type of ER stress and also showed variable levels of induction in independent neuron cultures. Nevertheless, relative to the DMSO control, each of the pharmacological inducers of ER stress (BFA, TM, or Thps) induced expression of many of the ERSE-26 genes in at least one human neuron culture (Fig. 2A) . To assess the levels of mRNA in a more quantitative manner, qPCR was conducted on a few ERSE-26-containing genes (Fig. 2B) . Compared with the DMSO control, the three ER stressors significantly increased the levels of HSPA5 and XBP1. While the levels of HSPA5 mRNA were similarly increased by each of three ER stressors, the fold increase XBP1 levels varied considerably (20 to 60 fold). PRNP mRNA levels increased by 3 to 8 fold with the three different ER stressors. ERLEC1 mRNA levels increased 4-6 fold with BFA and TM, but not Thps. GADD45B mRNA increased 2-fold with Thps only. SESN2 levels increased significantly 8 to 12-fold with TM and Thps, whereas SCL38A5 levels were not significantly increased with any of the three ER stressors. These variable results probably reflect inherent differences in mRNA stability for different genes or the presence of other transactivating or silencing factors in the promoter of these genes. Furthermore, variability in response in different primary human neuron preparations indicates a potential influence of the genetic background on the ER stress response. As a negative control, neurons were submitted to serum deprivation as another stress. Compared to either the DMSO control or non-treated cells, the mRNA levels of the ERSE-26 containing genes did not increase and neither did those of the ER stress regulated genes, HSPA5 or XBP1. Together, these results indicate that ER stress can modulate the expression of many ERSE-26 containing genes.
ERSE-26-containing genes are upregulated in ER stressed breast carcinoma MCF-7 cells
To determine if the variability observed in different human neuron preparations is dependent on the genetic background of the cells, we conducted the same experiments on the breast carcinoma MCF-7 cell line. qPCR results showed a more consistent induction of the various genes studied in independent experiments (Fig. 3A) . However, some of the genes responded differently to the three ER stressors. HSPA5 levels increased 35 fold with BFA but only 10-12 fold with TM and Thps treatments. Similar results were observed with PRNP and ERLEC1. In contrast, XBP1, GADD45B, SESN2 and SLC38A5 levels increased similarly with the three different ER stressors. Except for TM on SESN2, all ERSE-26 genes had a significant increase in gene expression with the three different ER stressors when compared to control DMSO treated cells. While the MCF-7 cells respond more consistently to ER stress than primary cultures of human neurons, there is also a differential response of these genes to different ER stressors. To determine if this differential response is dependent on XBP1 levels, MCF-7 cells were transfected with pCGN-EGFP-XBP1 or control vector pCGN-EGFP. As expected, sXBP1 mRNA levels were increased 25 fold over pCGN-EGFP-transfected cells (Fig. 3B) . HSPA5, PRNP, and ERLEC1 mRNA levels increased 2 to 3 fold with XBP1 expression, but neither GADD45B nor SESN2 mRNA levels were modulated by XBP1 overexpression.
Overexpression of XBP1 protein in transfected MCF7 cells was confirmed by western blotting (Fig.  3C) .We then tested the regulation of these genes by XBP1 in MCF-7 cells treated with BFA in the absence or presence of scrambled siRNA (siCtl) or siRNA against XBP1 (siXBP1). BFA increased the levels of sXBP1 mRNA in MCF-7 cells and thus provided a model to determine if sXBP1 can up-regulate ERSE-26 containing genes in live cells (Fig. 3D) . Unexpectedly, the HPRT1 mRNA levels varied with the different treatments and thus we had to use GAPDH mRNA levels to normalize instead of HPRT1. XBP1 mRNA level increased 2 fold in BFA-treated MCF-7 cells compared to the DMSO control treated cells (Fig. 3E) . The siXBP1 mRNA decreased these levels by 80%. PRNP, HSPA5, ERLEC1, and SESN2 mRNA levels increased with BFA treatment. In the presence of siXBP1, PRNP and ERLEC1 mRNA levels decreased by 50% but HSPA5 only slightly decreased. This is not unexpected since HSPA5 is regulated also by ATF6α and ATF4 (36,53). Furthermore, siXBP1 did not prevent BFAinduced SESN2 mRNA levels, consistent with the inability of the sXBP1 to upregulate this gene in MCF-7 cells (Fig. 3B) . GADD45B was not upregulated by BFA when normalized to GAPDH and basal levels were unaffected by the siXBP1. Lastly, we confirmed down-regulation of XBP1 protein in siXBP1-treated cells (Fig. 3E) . Together, these results show that ER stressinduced or overexpressed sXBP1 can transactivate ERSE-26 containing genes, but that the ERSE-26 motif is not always sufficient for sXBP1 transactivation.
Evidence for ERSE-26 physiological function.
To determine if the ERSE-26 motif is potentially transcribed by sXBP1 in a physiological condition, we examined available microarray datasets comparing the mRNA profiles of human XBP1-dependent B cell differentiation into plasma cells (Table V) (54) . In this array, XBP1 was upregulated 4.3 fold (Log2). All ERSE-26 genes identified by our bioinformatics analysis were present in the data set and 13 out of 38 showed a significant (adjusted p<0.05) Log 2 fold change in mRNA levels when activated B cells were differentiated into plasma cells. Of the 13 genes, ERLEC1 (2.4 fold), FOXO4 (1.29 fold), and YPEL3 (2.1 fold) were upregulated and PTGER4 was down-regulated (-2.3 fold). FOXO4 negatively regulates cell cycle and thus could be up-regulated to stop proliferation and allow differentiation of the B cells into plasma cells (55) . ERLEC1 is an ER resident protein that has been implicated in metastasis and survival of lung cancer cells, in the regulation of the unfolded protein response, and in trafficking of glycoprotein in the ER quality control system (56) . YPEL3 is associated with cellular senescence and is repressed in colon and mammary tumors, suggesting a novel role as a tumor suppressor (57) . PTGER4 promotes proliferation in endometrial cancers (58) . Therefore, these ERSE-26-containing genes could be implicated in differentiated plasma cells via XBP1.
Discussion
The role of ER stress in disease is broad; many conditions that disturb ER homeostasis by affecting protein folding can have large impacts on the physiological state of cells and organisms (2) . Here, we add the ERSE-26, as an ER stressdependent regulatory motif, to the already complex ER stress response. We show that the ERSE-26 (CCAAT-N26-CCACG), first identified in the human PRNP promoter (34), is transactivated by sXBP1 in a luciferase reporter system and mutagenesis of CCACG to ATCTA abolishes the ability of sXBP1 to transactivate the ERSE-26. Furthermore, we show that ER stressors in mammalian cells increased the levels of mRNA from genes containing ERSE-26 and other ER stress regulatory elements (PRNP, GADD45B) and in genes with no other known ER stress regulatory elements (ERLEC1 and SESN2). We also show that expression of sXBP1 in MCF-7 cells is sufficient to significantly increase PRNP gene expression and that siRNAs against XBP1 stunts the BFA-mediated increase of PRNP mRNA levels. This response is surprising since the canonical ERSE, CCAAT-N9-CCACG, is transactivated by ∆ATF6α, not sXBP1, and disruption of N9 abolishes ∆ATF6α transactivation of ERSE (36,37). In contrast, we find that ATF6α does not interact with nor transactivate ERSE-26. Our results suggest that CCAAT-NX-CCACG motifs present in gene promoters may have greater functionality in the response to ER stress than previously believed.
The bioinformatic search for gene promoters containing ERSE-26 identified 38 genes, including PRNP. Except for C6orf20, GADD45B and LRRC55, none of these genes had been previously identified as ERSE-containing or ER stress responsive genes. The function of the ERSE-26 genes was studied to determine if these could link the ER stress response via the ERSE-26 motifs with specific functions. One notable functional group was genes related to cell adhesion and synapse function. GAD2, LRFN4, LRRC55, and SLC38A5 all play a role in this process. GAD2 is one of two terminal rate-limiting enzymes that cleave glutamic acid into γ-Aminobutyric acid (GABA) (59). LRFN4, also known as SALM3, binds Post Synaptic Density 95 protein and induces neurite outgrowth (60) . LRRC55 enhances activity of calcium activated potassium channels (61) . Finally, SLC38A5, also known as SN2 or SNAT5, is an astrocyte expressed amino acid transporter that permits astrocytes to release glutamic acid for neurons to cleave to GABA (62) . Together with the suspected role of PrP at the synapse (reviewed by (63)), these results raise the possibility that ER stress regulates synaptic function in neurons through the ERSE-26 motif.
Another group identified oxidative stress function. Since protein folding is a redox-state dependent, energy-requiring process, overlap between the ER stress response and the oxidative stress response is logical. The genes NUDT9, TIMM44, SESN2 and GADD45B are localized in the mitochondria and respond to oxidative stress (64) (65) (66) (67) . GADD45B is an activator of pro-survival p38 MAPK signaling (66, 68, 69) . Both TIMM44 and NUDT9 localize to the mitochondria, and TIMM44 acts as a translocase to allow import of peptides/proteins to the inner mitochondrial membrane (70) . SESN2 and GADD45B are both regulated by p53 in response to environmental stresses (66, 71) . Interestingly, our results included a transcription factor FOXO4; the FoxO family of transcription factors regulate Sestrin family members, which suggests a possible feedback loop in ERSE-26 genes (64) . Finally, PRNP contains a p53-binding site, is induced in oxidative stress and protects cells against oxidative stress (8) (9) (10) (72) (73) (74) . Therefore, ER stress regulation via ERSE-26 in these genes may allow functions related to oxidative stress.
There is also evidence that some of the ERSE-26 genes are up-regulated in an XBP1-dependent manner during B cell differentiation into plasma cells. These results support a role for ERSE-26-dependent gene expression in a human physiological system.
Our results show that the fold increase in ER stress-mediated gene expression is highly variable and can be regulated by genetic background, cell type, and ER stressor. Furthermore, despite clear evidence that XBP1 regulates the ERSE-26 in the PRNP and the ERLEC1 promoters, not all ERSE-26 containing genes are upregulated by XBP1 only. Elucidating how and why the ER stress response is so variable remains to be determined but these results illustrate once again the complexity of the ER stress response. Nevertheless, our data identify a novel XBP1-regulated ERSE and reveals previously unknown ER stress-regulated genes.
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